Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40 shares of Common Stock at $567.27 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 49,973.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 240 shares of Common Stock at $569.0091 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 49,733.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 240 shares of Common Stock at $570.4073 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 49,493.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 445 shares of Common Stock at $571.1166 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 49,048.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 780 shares of Common Stock at $572.1669 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 48,268.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 677 shares of Common Stock at $573.4619 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 47,591.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,267 shares of Common Stock at $574.3118 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 46,324.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 680 shares of Common Stock at $575.3824 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 45,644.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 250 shares of Common Stock at $576.5458 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 45,394.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 1,217 shares of Common Stock at $577.3923 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 44,177.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 1,653 shares of Common Stock at $578.4786 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 42,524.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 678 shares of Common Stock at $579.3711 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 41,846.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 504 shares of Common Stock at $580.2201 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 41,342.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Sold 829 shares of Common Stock at $581.6802 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1, F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F16
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F17
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F18
• Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 53,288.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $576.96 to $577.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $577.96 to $578.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $578.96 to $579.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $579.98 to $580.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $581.08 to $582.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F16: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F17: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F18: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F2: This transaction was executed in multiple trades at prices ranging from $568.66 to $569.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $569.68 to $570.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $570.85 to $571.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $571.86 to $572.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $572.89 to $573.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $573.89 to $574.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $574.94 to $575.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $575.94 to $576.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.